Skip to main content

Table 2 Clinical-pathological characteristics of 11 nodal recurrences—institutional endometrial cancer database

From: Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma

Nodal recurrence

Age

Stage

Grade

LVSI

HIR

Nodal assessment

Adjuvant therapy

Nodal recurrence

Concurrent recurrence sites

I

57

1B

2

Present

Y

Pelvic

Vaginal brachytherapy

Pelvic

II

61

1A

2

Absent

N

Pelvic

Megestrol acetate

Pelvic

Lungs

III

54

1A

1

Absent

N

Pelvic

None

Pelvic

Vaginal vault

IV

72

1B

3

Present

Y

Pelvic and PA

Pelvic EBRT

Pelvic, para-aortic

V

65

1A

3

Present

Y

Pelvic and PA

None

Pelvic

Vaginal vault, bone

VI

52

1B

2

Present

Y

Pelvic

None

Pelvic

VII

64

1B

2

Present

Y

Pelvic

None

Pelvic

Vaginal vault

VIII

77

1B

3

Present

Y

Pelvic and PA

Vaginal brachytherapy

Pelvic

Abdomen

IX

67

1B

3

Present

Y

Pelvic

Pelvic EBRT

Mediastinum

X

70

1A

3

Present

Y

Pelvic

Pelvic EBRT

Mediastinum

Brain

XI

65

1A

3

Present

Y

Pelvic and PA

Chemotherapy

Para-aortic

Abdomen

  1. LVSI lymphovascular space invasion, HIR high-intermediate risk, Y yes, N no, EBRT external beam radiation therapy, PA para-aortic